Found 9 matching trials
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
PHASE2This study is being conducted to characterize the efficacy and safety of ni...
Status
Active Not Recruiting
Location
Nagoya University Hospital
A Trial In Patients With Advanced Cancer And Leukemia
PHASE1This is a phase 1, dose escalating study to determine the safety of PF-0308...
Location
Anschutz Cancer Pavilion
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
PHASE2This phase II trial studies the effects, good and bad, of gamma secretase i...
Location
Multiple Locations
A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors
PHASE1The purpose of this study is to determine the recommended Phase 2 dose for ...
Location
Multiple Locations
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
PHASE4This study is being conducted to study how nirogacestat may affect the ovar...
Location
Cliniques Universitaires Saint-Luc (CUSL)
Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
PHASE3This study evaluates nirogacestat (PF-03084014) in the treatment of desmoid...
Location
Arkansas Children's Hospital
Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat
PHASE1This study will evaluate the effects of the H2 blocker famotidine or the PP...
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
PHASE2Background:
* Desmoid tumors (also known as aggressive fibromatosis), are ...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
N/AThis is a single-center, open label, non randomized, compassionate use prot...
Status
No Longer Available
Location
University of Colorado